Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
NGO

International Association for the Study of Lung Cancer

Tracked across 2 events · 12 articles · First seen Jul 20, 2026 · Last active Sep 14, 2026

Sentiment
5
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 5
Tech
Akeso announced that a pre-specified interim analysis of overall survival (OS) in the Phase III HARMONi-2 (AK112-303) trial, assessed by the Independent Data Monitoring Committee, met the key secondary OS endpoint. Ivonescimab, Akeso's first-in-class PD-1/VEGF…
Impact: The IASLC organized the 2026 World Conference on Lung Cancer where the HARMONi-2 OS data were published and presented as a late-breaking abstract.
Jul 20, 2026 · 6 articles
2 5
Tech
Cullinan Therapeutics announced that it will host a virtual event for analysts and institutional investors on September 14, 2026, at 8:00 a.m. ET to discuss results from the planned interim analysis of the Phase 3…
Impact: The International Association for the Study of Lung Cancer hosts the WCLC where the REZILIENT3 interim data were presented, providing the scientific venue for the disclosure.
Sep 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track International Association for the Study of Lung Cancer live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.